Pharmaceutical Protein Drug Development

7.5 credits

Course, Master's level, 3FB031

Expand the information below to show details on how to apply and entry requirements.

Location
Uppsala
Pace of study
100%
Teaching form
On-campus
Instructional time
Daytime
Study period
18 January 2027–21 February 2027
Language of instruction
English
Entry requirements

150 credits, including 90 credits in biomedicine, pharmaceutical science, chemistry, natural science and/or engineering, and Biological Drugs, 7.5 credits. Proficiency in English equivalent to the Swedish upper secondary course English 6.

Selection

Higher education credits (maximum 285 credits)

Fees
If you are not a citizen of a European Union (EU) or European Economic Area (EEA) country, or Switzerland, you are required to pay application and tuition fees.
  • First tuition fee instalment: SEK 20,625
  • Total tuition fee: SEK 20,625

Read more about fees.

Application deadline
15 October 2026
Application code
UU-89219
Apply now

Admitted or on the waiting list?

Information on registration from the department

About the course

Through the course, you will understand how to develop a protein-based biological drug further after the initial proposed design of the drug. You will work on designing experiments to analyse if the biological drug has the predicted effect and in-depth formulate which indication you should treat and which diagnostic tools can be used to find the right patient group. They will also develop a target products profile (TPP) for the drug candidate and based on this formulate a quality TPP. With this base, they will learn more about analytical tools that can be used during the process development of a drug and also gain an understanding of how the drug and/or its effects can be measured in biological samples by e.g. mass spectrometry.

Contact